Genosco

Genosco

Biotechnology, 43 Manning Rd, Billerica, , 1821, Massachusetts, United States, 11-50 Employees

genosco.com

  • twitter
  • LinkedIn

phone no Phone Number: 16*********

Who is GENOSCO

Genosco is a clinical-stage biotech pursuing discovery and development of novel small-molecule drugs for patients with unmet medical needs. Our proprietary G-SMARTTM platform enables disc...

Read More

map
  • 43 Manning Rd, Billerica, Massachusetts, 1821, United States Headquarters: 43 Manning Rd, Billerica, Massachusetts, 1821, United States
  • 2008 Date Founded: 2008
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies
  • Jong Koh CEO:   Jong Koh

industries-icon Industry: Biotechnology

SIC SIC Code: 2834 | NAICS Code: 325412 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from GENOSCO

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Genosco

Answer: Genosco's headquarters are located at 43 Manning Rd, Billerica, , 1821, Massachusetts, United States

Answer: Genosco's phone number is 16*********

Answer: Genosco's official website is https://genosco.com

Answer: Genosco's revenue is $1 Million to $5 Million

Answer: Genosco's SIC: 2834

Answer: Genosco's NAICS: 325412

Answer: Genosco has 11-50 employees

Answer: Genosco is in Biotechnology

Answer: Genosco contact info: Phone number: 16********* Website: https://genosco.com

Answer: Genosco is a clinical-stage biotech pursuing discovery and development of novel small-molecule drugs for patients with unmet medical needs. Our proprietary G-SMARTTM platform enables discovery and optimization based on rare sequences in protein kinases that can be targeted to develop a highly selective compound. This innovative approach has enabled us to build a strong portfolio of multiple independent and partnered pipelines. Our most advanced pipeline, Lazertinib, is currently undergoing phase 3 global clinical trial by Janssen and is also available in Korea for patients with EGFRm+ non-small cell lung cancer. Robust research and discovery programs are also underway. With a shared mission to enhance peoples lives through innovative science, we are united in developing world-class precision medicine to help people have healthier and longer lives. Our interdisciplinary team consists of scientists with deep expertise in medicinal chemistry, structural & computational drug discovery design, cell biology, pharmacology, and drug metabolism.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access